Participation of cyclooxygenases in cutaneous thermal nociception under non-inflamed and inflamed conditions

Inflammation Research

Volumn 50, Issue 5, 2001, Pages 283-287

  Suzuki, M ^a   Hayashi, I ^a,b   Nara, Y ^b   Kumagai, Y ^a,b   Okamoto, H ^b   Hoka, S ^b   Majima, M ^a,b  

^a KITASATO UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclooxygenases; Hyperalgesia; Lipopolysaccharide; Non steroidal anti inflammatory drugs; Thermal nociception

Indexed keywords

CYCLOOXYGENASE 2; INDOMETACIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; MOFEZOLAC; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN SYNTHASE INHIBITOR; TILMACOXIB;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; INFLAMMATION; MALE; NOCICEPTION; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CYCLOOXYGENASE INHIBITORS; HEAT; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; NOCICEPTORS; PAIN MEASUREMENT; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN;

EID: 0034999954     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050755     Document Type: Article

References (33)

1. [1] Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977; 4: 161-74.
2. [2] Koster R, Anderson M, DeBeer EJ. Acetic acid for analgesic screening. Fed Proc 1959; 18: 412.
3. [3] Siegmund E, Cadmus R, Lu G. A method for evaluating both non-narcotic and narcotic analgesics. Proc Soc Exp Biol Med 1957; 95: 729-31.
4. [4] D'Amour F, Smith D. A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941; 72: 74-9.
5. [5] Woolfe G, MacDonald A. The evolution of the analgesic action of pethidine hydrochloride (Demerol). J Pharmaco Exp Ther 1944; 80: 300-7.
6. [6] Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn 1957; 4: 409-19.
7. [7] Davies P, Bailey PJ, Goldenberg MM, Ford-Hutchinson AW. The role of arachidonic acid oxygenation products in pain and inflammation. Ann Rev Immunol 1984; 2: 335-57.
8. [8] Merlie JP, Fagan D, Mudd J, Needlemann P. Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J Biol Chem 1988; 263: 3550-3.
9. [9] Funk CD, Func LB, Kennedy ME, Pong AS, Fitzgerald GA. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J 1991; 5: 2304-12.
10. [10] Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991; 266: 12866-72.
11. [11] O'Neill PO, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 1993; 330: 156-60.
12. [12] Vane JR. Inhibition of prostaglandin biosynthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 1971; 231: 232-5.
13. [13] Wallace JL. Mechanisms of nonsteroidal anti-inflammatory drugs (NSAIDs) induced gastrointestinal damage-potential for development of gastrointestinal tract safe NSAIDs. Can J Physiol Pharmacol 1994; 72: 1493-8.
14. [14] Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32: 77-88.
15. [15] Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 1994; 47: 55-9.
16. [16] Kusuhara H, Matsuyuki H, Okumoto T. Effects of nonsteroidal anti-inflammatory drugs on interleukin-1 receptor antagonist production in cultured human peripheral blood mononuclear cells. Prostaglandins 1997; 54: 795-804.
17. [17] Goto K, Ochi H, Yasunaga Y, Matsuyuki H, Imayoshi T, Kusuhara H, Okumoto T. Analgesic effect of mofezolac, a non-steroidal anti-inflammatory drug, against phenylquinone-induced acute pain in mice. Prostaglandins Other Lipid Mediat 1998; 56: 245-54.
18. [18] Matsushita M, Masaki M, Yagi Y, Tanaka T, Wakitani K. Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats. Inflamm Res 1997; 46: 461-6.
19. [19] Bennett GJ, Xie Y-K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33: 87-107.
20. [20] Euchenhofer C, Maihofher C, Brune K, Tegeder I, Geisslinger G. Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat. Neurosci Lett 1998; 248: 25-8.
21. [21] Futaki N, Yoshikawa K, Hamasaka Y, Arai I, Higuchi S, Iizuka H, Otomo, S. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen Pharmacol 1993; 24: 105-10.
22. [22] Matsumoto H, Fujiyoshi T, Murakami M, Kudo I, Oh-ishi S. Induction of cyclooxygenase-2 causes an enhancement of writhing response in mice. Eur J Pharmacol 1998; 352: 47-52.
23. [23] Kusuhara H, Matsuyuki H, Okumoto T. Involvement of prostaglandins produced by cyclooxygenase-1 in murine visceronociception induced by phenylquinone. Prostaglanidns Other Lipid Mediat 1998; 55: 43-9.
24. [24] Dirig DM, Isakson PC, Yaksh TL. Effect of COX-1 and CX-2 inhibitor on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats. J Pharmacol Exp Ther 1998; 285: 1031-8.
25. [25] O'Banion MK, Sadowski HB, Winn V, Young DA. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 1991; 266: 23261-7.
26. [26] Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991; 88: 2692-6.
27. [27] Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992; 89: 7384-8.
28. [28] Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Staffer A, Talley JJ, Masferrer JL, Seibert K, Isakson PC. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 1998; 95: 13313-8.
29. [29] Hay CH, Trevethick MA, Wheeldon A, Bowers JS, de Belleroche JS. The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia. Neurosci 1997; 78: 843-50.
30. [30] Yamamoto T, Nozaki-Taniguchi N. Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor. Brain Res 1996; 739: 104-10.
31. [31] Taiwo YO, Levine JD. Effects of cyclooxygenase products of arachidonic acid metabolism on cutaneous nociceptive threshold in the rat. Brain Res 1990; 537: 372-4.
32. [32] Beck PW, Handwerker HO. Bradykinin and serotonin effects on various types of cutaneous nerve fibers. Pflugers Arch 1974; 347: 209-22.
33. [33] Baccaglini PI, Hogan PG. Some rat sensory neurons in culture express characteristics of differentiated pain sensory cells. Proc Natl Acad Sci USA 1983; 80: 594-8.